This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Abrysvo ® (Respiratory syncytical virus vaccine [bivalent, recombinant] ) United Kingdom (UK)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

  • Abrysvo (Respiratory syncytical virus vaccine [bivalent, recombinant]) powder and solvent for solution for injection- PI for UK
PP-A1G-GBR-0230 January 2025